Resolution of complex fluorescence spectra of lipids and nicotinic acetylcholine receptor by multivariate analysis reveals protein-mediated effects on the receptor's immediate lipid microenvironment by Wenz, Jorge Javier & Barrantes, Francisco Jose
BioMed CentralPMC Biophysics
ssOpen AcceResearch article
Resolution of complex fluorescence spectra of lipids and nicotinic 
acetylcholine receptor by multivariate analysis reveals 
protein-mediated effects on the receptor's immediate lipid 
microenvironment
Jorge J Wenz and Francisco J Barrantes*
Address: UNESCO Chair of Biophysics and Molecular Neurobiology and Instituto de Investigaciones Bioquímicas de Bahía Blanca, B8000FWB 
Bahía Blanca, Argentina
Email: Jorge J Wenz - jwenz@criba.edu.ar; Francisco J Barrantes* - rtfjb1@yahoo.com
* Corresponding author    
Abstract
Analysis of fluorescent spectra from complex biological systems containing various fluorescent
probes with overlapping emission bands is a challenging task. Valuable information can be extracted
from the full spectra, however, by using multivariate analysis (MA) of measurements at different
wavelengths. We applied MA to spectral data of purified Torpedo nicotinic acetylcholine receptor
(AChR) protein reconstituted into liposomes made up of dioleoylphosphatidic acid (DOPA) and
dioleoylphosphatidylcholine (DOPC) doped with two extrinsic fluorescent probes (NBD-
cholesterol/pyrene-PC). Förster resonance energy transfer (FRET) was observed between the
protein and pyrene-PC and between pyrene-PC and NBD-cholesterol, leading to overlapping
emission bands. Partial least squares analysis was applied to fluorescence spectra of pyrene-PC in
liposomes with different DOPC/DOPA ratios, generating a model that was tested by an internal
validation (leave-one-out cross-validation) and was further used to predict the apparent lipid molar
ratio in AChR-containing samples. The values predicted for DOPA, the lipid with the highest Tm,
indicate that the protein exerts a rigidifying effect on its lipid microenvironment. A similar
conclusion was reached from excimer formation of pyrene-PC, a collisional-dependent
phenomenon. The excimer/monomer ratio (E/M) at different DOPC/DOPA molar ratios revealed
the restricted diffusion of the probe in AChR-containing samples in comparison to pure lipid
samples devoid of protein. FRET from the AChR (donor) to pyrene-PC (acceptor) as a function of
temperature was found to increase with increasing temperature, suggesting a shorter distance
between AChR and pyrene PC. Taken together, the results obtained by MA on complex spectra
indicate that the AChR rigidifies its surrounding lipid and prefers DOPA rather than DOPC in its
immediate microenvironment. 
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The nicotinic acetylcholine receptor (AChR) is an oligo-
meric protein deeply embedded in a lipid microenviron-
ment that differs in physical terms from the rest of the
membrane bilayer: the AChR is surrounded by boundary
("annular", "shell") lipid [1,2] that is immobilized rela-
tive to the bulk bilayer lipid in native membranes derived
from Torpedo postsynaptic membrane. The lipid bilayer
beyond the lipid annulus has also been reported to be
affected, albeit to a lesser extent, by the presence of the
AChR protein [reviewed in [3,4]]. The boundary lipid has
a lesser degree of water penetration than the bulk lipid
bilayer and has the characteristics of the liquid-order (lo)
lipid state [5], similar to that purported to occur in the so-
called "raft" lipid domains. In reconstituted cholesterol
(Chol)-containing liposomes, AChR apparently deter-
mines the lateral phase separation of certain phospholip-
ids such as phosphatidic acid (PA), but not of others
(phosphatidyl-choline, -ethanolamine or -glycerol), caus-
ing the formation of lipid domains segregated from the
bulk lipid matrix [6]. Incorporation of AChR into pure
phosphatidylcholine (PC) liposomes stabilizes the AChR
in a nonresponsive, desensitized state, whereas reconstitu-
tion into PA- or Chol-containing liposomes favors a func-
tional, resting state of the AChR. There is an increase in
both the lateral packing density and phase transition tem-
perature of reconstituted bilayers composed of some lipid
mixtures (POPC/DOPA or POPC/POPA) but not others
(POPC) [7], suggesting a differential interaction with
membrane lipids.
Fluorimetric methods are extensively used to study the
lipid organization in bilayers in combination with appro-
priate (intrinsic or extrinsic) fluorescent probes. Even after
careful design and correct experimental performance,
however, with suitable fluorescence spectra being
recorded, the experimentalist is often frustrated by the
paucity of information that can be extracted by direct
examination of spectral data. Analysis of fluorescent spec-
tra from complex biological systems containing various
components and fluorescent probes with overlapping
emission bands and/or interfering signals is therefore not
an easy task [8]. Valuable information can be extracted
from the full spectra, however, by using multivariate anal-
ysis (MA) of measurements at different wavelengths, as
they allow the extraction of information that is not imme-
diately apparent by simple visual inspection of the spectra
[9]. Thanks to the availability of digitized spectroscopy
data and powerful software, multivariate calibration
methods are playing an increasingly important role
because of their ability to exclude known or unknown
interfering signals from the calculus. In complex mixtures,
laborious and time- and reagent-consuming chemical sep-
aration techniques are usually needed to eliminate such
interfering compounds (if at all possible). MA on the
other hand can save time and effort since all that it
requires is a carefully designed experiment and a reasona-
ble amount of computing time. The analysis is carried out
in several stages: a) a calibration step, in which a mathe-
matical relationship between the spectra and the compo-
nent concentration(s) is established from a set of
reference samples; b) a validation step, where the per-
formance of the regression model is tested using a set of
reference samples (either the same one used to construct
the model or a different one); and c) use of the validated
model to determine the component concentrations in
unknown samples from their whole spectra. A "weight" is
assigned to each measured variable (e.g. wavelength) by
attributing a coefficient in the regression model according
to the variable's influence on the model and its correla-
tion with the known dependent variable (e.g. concentra-
tion). The precision of the calculations is drastically
improved by enhancing the probability of detecting
experimental errors and/or anomalous samples [10-12].
In the present work we make use of Partial Least Squares
(PLS-1) [13] as a multivariate tool to ascertain the influ-
ence of the AChR protein on the lipid organization and
fluidity of reconstituted lipid membranes. To our knowl-
edge, multivariate methods have so far not been
employed in fluorescence studies of protein-lipid interac-
tions in biomembranes. The initial model aimed at pre-
dicting the "apparent" molar fraction of dioleoyl-
phosphatidic acid (DOPA) (and its counterpart, dioleoyl-
phosphatilcholine, DOPC) in AChR-containing mem-
branes. To this end the fluorescence emission spectra of
AChR-free liposomes were initially correlated with vary-
ing molar fractions of DOPA in the mixture. The excimer
to monomer ratio of pyrene-phosphatidylcholine (PyPC),
which also reports on bilayer fluidity and organization
[14,15], was studied next in AChR-free and receptor-con-
taining samples as a function of DOPA molar fraction
using spectral analysis of the emission bands of the two
species of PyPC. Finally, the apparent Förster resonance
energy transfer (FRET) from AChR to PyPC was also inves-
tigated by MA of areas in the emission spectra of donor
and acceptor bands. The combined approaches yield an
integrated view of the spectral properties of the complex
mixtures of AChR and lipids, enabling us to extract valua-
ble information on the interaction between the two.
2. Methods
2.1. Materials
Frozen electric organs from Torpedo californica were
obtained from Aquatic Research Consultants (San Pedro,
CA) and stored at -70°C until further use. DOPA, DOPC
and Chol were obtained from Avanti Polar Lipids, Inc
(Alabaster, AL). NBD-Chol and cholic acid were pur-
chased from Sigma Chemical (St. Louis, MO). PyPC was
obtained from Molecular Probes Inc. (Eugene, OR, USA).Page 2 of 12
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chased from Promega (Madison, USA). All other reagents
were analytical quality. Lipid stock solutions were pre-
pared in chloroform/methanol (2:1 v/v) at a concentra-
tion of 0.5 mg/ml and 0.05 mg/ml for PyPC. All solutions
were stored at -20°C before use.
2.2. Purification of the AChR protein from AChR-enriched 
membranes
All steps were carried out at 4°C. AChR-enriched mem-
branes from electric tissue of Torpedo californica were pre-
pared as described previously [16]. The AChR protein was
purified from these membranes by affinity chromatogra-
phy using Affi-Gel 10 resin (Bio-Rad Laboratories, CA,
USA) previously activated as described elsewhere [17]
with slight modifications. Briefly, the affinity column was
prepared by coupling cystamine to the matrix, reduction
of disulphide bonds with dithiotreitol and a final activa-
tion with bromoacetylcholine bromide. Derivatization of
the gel was followed qualitatively in each step by assaying
for sulfhydryl groups with DTNB (5,5'-dithiobis (2-
nitrobenzoic acid)). The activated gel was stored at 4°C
and used within a month.
AChR-enriched membranes with a protein concentration
of 6–7 mg/mL were obtained from 90 g of electric tissue
and brought to a protein concentration of 2 mg/mL in
MOPS buffer (10 mM MOPS, 0.1 mM EDTA, 100 mM
NaCl, 0.02% sodium azide (w/v), pH 7.4). Membranes
were solubilized by adding cholic acid to give a final con-
centration of 1% (w/v) with gentle stirring for 20 min. The
detergent extract was centrifuged in a Ti 70 rotor at 34,000
rpm for 45 min. Ten ml of the activated affinity column
were washed with 4–5 volumes of water followed by 2
volumes of MOPS buffer containing 1% cholate, and the
supernatant was applied to the column. To exchange
native lipids for the desired exogenous lipid (reconstitu-
tion), the column was pre-equilibrated with the following
sequence of DOPC solutions in MOPS buffer-1% cholate:
4 vol of 0.1 mg/mL, 2.5 vol of 2 mg/mL and 3 vol of 0.1
mg/mL. The AChR was eluted by applying 3 vol of MOPS
buffer-1% cholate, 10 mM carbamoylcholine chloride
and 0.1 mg/mL DOPA or DOPC. Protein concentration
was monitored by measuring A280 and fractions with val-
ues greater than 0.1 were pooled. To eliminate cholate
and carbamoylcholine, and in order to form vesicles, the
mixture was dialyzed using 12,000 MW cut-off cellulose
membranes at 4°C against 200 volumes of MOPS buffer,
with gentle stirring for 40 h and buffer replacement every
8 h.
2.3. Characterization of purified AChR
To verify the purity of the AChR protein, SDS-gel electro-
phoresis was performed under denaturing conditions [18]
using 0.75 mm thick gels and 10% total acrylamide con-
centration. Electrophoresis was carried out in a Mini Pro-
tean II Cell (BioRad laboratories, Inc., CA, USA) for 3 h at
15 mA, supplied by a Power Pack 3000 (BioRad). AChR
subunits were visualized using a silver staining kit (Amer-
shan, Uppsala, Sweden) and identified by comparison
with mid-range protein molecular weight markers.
Protein concentration was assayed according to [19]. Lip-
ids were extracted as described in [20] and assayed for
inorganic phosphorus content according to [21]. Total
lipid concentration was 0.12 mg/mL (0.163 mM).
2.4. Lipid suspension and re-reconstitution of purified 
AChR
Lipid suspensions were prepared by mixing the appropri-
ate amount of stock solution of each component to obtain
mixtures of DOPA/DOPC with different molar ratios,
ranging from pure DOPA to pure DOPC but always total-
ing 60 mol%. NBD-Chol and PyPC concentrations were
maintained at 40% and 5%, respectively; the latter was
computed over the final lipid concentration of each sam-
ple: 40 μM (see Table 1). Taking into account the lipids
contained in the purified AChR preparation, the lipid to
protein ratio was calculated and adjusted in order to
achieve the desired lipid and protein concentrations upon
subsequent incorporation of purified AChR into the sam-
ples.
The lipid mixtures were dried under nitrogen at room
temperature while rotating the round-bottomed tubes to
form the lipid film. NBD-Chol was highly adherent to
glass tubes and almost insoluble in MOPS buffer contain-
ing 1% cholate. Heating, sonication and/or vortexing for
more than half an hour did not improve the solubiliza-
tion of the lipids, nor did increasing the cholic acid con-
tent up to 25% (w/v). To circumvent this problem, the
dried film was resuspended in 7.5 μL methanol with vor-
texing for 2 min, followed by addition of MOPS buffer
Table 1: Composition of liposomes used in fluorescence 
experiments.
Mol %
Sample No.: 1 2 3 4 5 6 7 8 9 10
PyPC 0 0 5
DOPA 50 20 20 60 50 40 30 20 10 0
DOPC 50 40 40 0 10 20 30 40 50 60
NBD-Chol 0 40
Samples 1 and 2 are control liposomes; sample 3 corresponds to the 
AChR-containing liposomes, with a lipid to protein molar ratio of 
500:1. Excluding PyPC (5 mol% extra), final lipid concentration was 40 
μM for all samples, amounting to 100%. Except for sample 2, all other 
samples were assayed in duplicate.Page 3 of 12
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the final methanol concentration was thus 0.5% (v/v).
Since DOPA and DOPC have low temperatures (-8 and -
20°C, respectively) this step could be accomplished at
room temperature (i.e. a temperature higher than that of
the highest Tm of the constitutive lipids). At this stage, the
total lipid concentration of the suspension was 0.5 mg/
mL. Samples were then vigorously vortexed for 2 min.
The purification procedure yielded membranes with a
lipid to protein ratio of 45:1 (mol:mol). Purified AChR
protein (0.2 mg/mL) was added to aliquots of the suspen-
sion, yielding re-reconstituted membranes with a lipid to
protein ratio of 500:1 (mol:mol) and a DOPA/DOPC/
NBD-Chol molar ratio of 20/40/40, keeping the total
lipid concentration at 40 μM (Table 1). In order to elimi-
nate cholate and form vesicles, the mixtures were dialyzed
using 12,000 MW cut-off cellulose membranes at 4°C
against 200 volumes of MOPS buffer, with gentle stirring
for 40 h and buffer replacement every 12 h.
2.5. Fluorescence measurements
Fluorescence emission spectra were recorded with an SLM
4800 ISC spectrofluorimeter (SLM Instruments, Urbana,
IL) with a light beam from a Hannovia 200 W mercury/
xenon arc. Measurements were carried out in 5 × 5 mm
quartz cuvettes in the temperature range of 25–55°C.
Optimal excitation wavelengths for AChR, PyPC and
NBD-Chol were 290, 340 and 478 nm, respectively. Fluo-
rescence emission spectra were obtained 15 min after
reaching the desired working temperature, which was reg-
ulated by a thermostated circulating water bath (Haake,
Darmstadt, Germany) with a heating rate of 0.5°/min
monitored inside the cuvette with a thermocouple. Back-
ground fluorescence was measured in samples made up of
pure DOPA/DOPC (50:50 mol/mol) mixtures, and sub-
tracted from probe-containing samples. The fluorescence
intensity of these background samples amounted to less
than 5–10% of that of the probe-containing counterpart.
In FRET experiments samples were excited at 290 nm and
fluorescence emission spectra of AChR (F330nm), PyPC
(F374nm and F474nm) and NBD (F534nm) were recorded.
2.6. Multivariate analysis of fluorescence spectra
Univariate calibration is when one response of e.g. an
instrument (absorbance, fluorescence, chromatographic
peak, etc.) is related to the concentration of a single com-
ponent. Multivariate calibration, on the other hand,
relates multiple measurements and/or responses of an
instrument (i.e. fluorescence intensity at several wave-
lengths, spectrum) to a property or properties of a sample.
This offers several advantages over univariate approaches:
a) information from multiple measured variables can be
extracted and exploited; b) it is possible to analyze multi-
ple components simultaneously, which is difficult with
univariate analysis; c) significant variables can be selected
by weighing their importance, discarding those that are
uncorrelated with a given dependent variable; d) the use
of multiple variables can also improve precision in predic-
tion, since statistics demonstrate that repeating a measure-
ment n times and calculating a mean value will result in a
factor of vn reduction in the standard deviation of the
mean; and e) it enhances the detection of errors, interfer-
ences and/or anomalous samples, given that the likeli-
hood that these failures affect the response in all the
variables decreases as the number of variables increases
[10,11]. One of the advantages of "inverse" methods of
multivariate calibration and prediction (MLR, Multiple
Linear Regression; PCR, Principal Component Regression
and PLS-1, Partial Least Squares) over "classical" methods
(DLCS, Direct Classical Least Squares and ICLS, Indirect
Classical Least Squares) is their ability to generate good
predictive models in complex systems with known and/or
unknown components [10]. Their ability to implicitly
model all sources of variation means that they can per-
form appropriately even if additional, chemical or physi-
cal sources of variation such as interferences are present in
the samples. The proper functioning of such models
requires that the measurements adequately differentiate
the component of interest from other sources of variance
and that the measurements and/or instrument responses
vary in a sufficiently linear manner with the concentra-
tion. In practice, this means that much less explicit knowl-
edge of the system and potential interferences is required,
but that the calibration step may involve more work than
when using "classical" methods.
Among the multivariate approaches, PLS-1 is undoubt-
edly the most widely used method for constructing math-
ematical models able to predict properties (e.g.
concentration of a compound) of unknown samples
given an instrument output (e.g. spectrum). The a priori
calibration step relating known concentrations of a com-
pound in reference samples with their full spectra permits
the building of a mathematical model relating the spectral
data to the concentration of the compound. This model
can then be used to predict the concentration of the com-
pound in unknown samples on the basis of their spectra.
3. Results
3.1. Pre-processing of the spectra and selection of 
appropriate wavelengths
"Pre-processing" commonly refers to any mathematical
manipulation of data prior to primary analysis (e.g. PLS-1
in the present study) and is used to remove or reduce irrel-
evant sources of variation, random or systematic. It can
operate on one variable at a time over all samples, or on
one sample at a time over all variables (the present case).
Here the operational definition of "pre-processing" refers
to the smoothing and normalization of all samples at allPage 4 of 12
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interval. The pre-processed data were subsequently used
in the "processing" step proper, i.e. PLS-1 analysis. Fig. 1A
shows the raw fluorescence emission spectra of AChR-free
liposomes with varying DOPA and DOPC molar fractions
(0–60%) and AChR-containing liposomes with a DOPA
and DOPC molar fraction of 20 and 40%, respectively, at
the excitation wavelength of PyPC (340 nm).
Even though the fluorescent probe concentration was kept
constant (see Table 1), noticeable differences in the fluo-
rescence intensity were apparent at all wavelengths in raw
spectra (Fig. 1A). Direct examination of the spectral data
did not provide conclusive information, which is not sur-
prising in view of the complex nature of the biological
samples.
In order to eliminate experimental and instrumental noise
of the recorded spectra, the data were initially smoothed
using the Savitsky-Golay procedure, with a window width
of 8 points (i.e. wavelengths). The middle point of the
interval was then estimated using a second-order polyno-
mial fit, whereby four points at the beginning and the end
of each spectrum were left out by the averaging procedure.
The spectra were subsequently normalized to their highest
intensity value, i.e. to the first peak (374 nm) of the PyPC
monomer band, which spans an area between 358 and
434 nm. The resulting data (Fig. 1B) showed more clearly
the section of the spectrum where the most noticeable
changes in fluorescence intensity occurred: a restricted
region (434–590 nm, rectangle in Fig. 1B) corresponding
to the PyPC excimer (first band, ~474 nm) and the fluo-
rescent Chol analogue NBD-Chol (second band, ~534
nm) emission bands. The spectral window chosen reports
on the changing DOPA molar fraction (and hence on the
DOPC molar fraction). NBD-Chol acts as an energy trans-
fer acceptor of the PyPC donor (NBD-Chol excitation
wavelength, 460 nm). The reference spectra of the individ-
ual probes are shown in Additional file 1.
3.2. Constructing the model
After selecting the useful spectral region, PLS-1 was used
to construct a model relating the DOPA molar fraction of
14 AChR-free samples to their spectra [22]. Though in this
instance the DOPA molar fraction was chosen as a varia-
ble, the DOPC molar fraction should in fact yield similar
results since the two are inversely correlated and the sum
of their molar fractions amounts to 60% in all samples.
The pre-selected 79 x-variables were thus the fluorescence
intensity at each wavelength, collected every 2 nm in the
chosen interval (434–590 nm). The model was con-
structed by using 1 to 6 factors (also called principal com-
ponents, "PC"), computed in a data matrix of 14 samples
× 79 variables. Since a requisite for inverse methods is that
the number of factors calculated must be less than or
equal to the number of calibration samples or the number
of variables, an internal validation using a "leave-one-out
cross-validation" procedure was performed in order to test
the model. Here, one sample was left out, a model with a
given number of factors was calculated using the remain-
ing samples, and the residual of the left-out sample was
calculated after predicting its value with the model. This
was repeated for each sample and for models with 1 to 6
factors. Because of its high residual (i.e. "outlier" value),
one sample was removed and 13 samples were then used
for model building. The optimal number of factors was
found to be 4 on the basis of the lowest RMSEP and high-
est explained y-variance values (see Additional file 2).
3.3. "Apparent" DOPA and DOPC molar fraction in AChR-
containing samples
The model constructed with 4 factors was used next to
evaluate the apparent DOPA molar fraction in AChR-con-
taining liposomes with a known DOPA molar fraction of
20%. The predicted DOPA molar fraction for all samples
at 25°C versus the corresponding known values is shown
in Fig. 2A together with their corresponding deviation,
which reflects the degree of similarity between the pre-
dicted values and the calibration samples used for build-
ing the model. For each sample the deviation (95%
confidence interval) is computed as a function of the sam-
ple's leverage and its x-residual variance. The higher the
similarity, the smaller the deviation. A high correlation
was found between known and predicted DOPA molar
fractions in the AChR-free samples (r2 = 0.991), reinforc-
ing the validity of the model.
For the two AChR-containing samples assayed, the pre-
dicted DOPA fraction was considerably higher (64 and
82%) than its actual value (20%). DOPA has a higher
transition temperature (-8°C) than DOPC (-20°C). This
implies that the AChR rigidifies its lipid microenviron-
ment: the observed bilayer packing is as high as that cor-
responding to the predicted DOPA molar fraction. The
portion of the spectra employed to construct the model
(434–590 nm) matches the emission band of the PyPC
excimer (see Fig. 3 below), which informs on membrane
fluidity. The variability found in this portion of the spectra
after normalization to the highest value (first peak of the
PyPC monomer) reports on excimer formation, related to
membrane fluidity.
PLS-1 was applied next to the raw (Fig. 1A) and
smoothed, normalized spectra (Fig. 1B) of AChR-free
samples in the entire wavelength interval (354–590 nm).
The model obtained from the raw data performed poorly
(Fig. 2B) compared to that corresponding to the selected
region of high variability as revealed by smoothing and
normalization of the spectra. In statistical terms, this
poorer performance was reflected in: a) a higher numberPage 5 of 12
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Pre-proccesing of spectra and selection of appropriate wavelengthsFigure 1
Pre-proccesing of spectra and selection of appropriate wavelengths. A) Raw fluorescence emission spectra of various 
AChR-free liposomes with varying molar ratios of DOPA/DOPC (ranging from 0 to 60%) and two AChR-containing liposomes 
with DOPA/DOPC (20:40). Two replicas from independent experiments are shown. In all samples, NBD-Chol and PyPC con-
centrations were kept at 40 and 5%, respectively. The final lipid concentration and the lipid to protein molar ratio in the AChR-
containing liposomes were 40 μM and 500:1, respectively. Excitation wavelength = 340 nm. Temperature = 25°C. B) Pre-proc-
essed spectra obtained by smoothing throughout the Savitsky-Golay procedure (with a window width of 8 points and a second 
order polynomial fit) and normalizing to the highest value of each spectrum (corresponding to the first PyPC emission band at 
374 nm). The wavelengths further employed for the multivariate analysis are outlined in the dotted rectangle. It is clear that the 
sixteen spectra in each panel are difficult to identify due to their high degree of overlap; this is precisely what multivariate anal-
ysis dissects so effectively. Where possible, spectra have been identified with the sample numbers appearing in Table 1.
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Predicted versus known DOPA molar fractionFigure 2
Predicted versus known DOPA molar fraction. A-C) Comparison of the predictive performance of PLS-1 models con-
structed from either pre-processed or unprocessed spectra from samples at 25°C. A) Model obtained after smoothing and 
normalizing the full spectra, followed by a selection of a restricted portion of wavelengths (434–590 nm, Fig. 1B). B) Model con-
structed with the raw and full spectra (354–590 nm, Fig. 1A). C) Model constructed with the smoothed, normalized and full 
spectra (354–590 nm). Statistical parameters, reflecting the model's performance, are shown in each panel (see text for 
details). Each model was tested by leave-one-out cross-validation. Since the model shown in (A) displayed the highest predic-
tive performance, it was used to estimate the DOPA molar fraction in AChR-containing samples at 25°C. Models obtained at 
40°C (panel D) and 55°C (panel E) from pre-processed spectra. Bars represent deviation, expressing the degree of similarity 
between the predicted samples and the calibration samples used to build each model. Deviation (95% confidence interval 
around the predicted value) is computed as a function of the sample's leverage and its x-residual variance. After removing out-
liers, linear equations in each plot were computed using the remaining numbers of AChR-free samples: 13 in (A), 14 in (B) and 
(C), 13 in (D) and 12 in (E).
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Excimer to monomer ratio of PyPCFigur  3
Excimer to monomer ratio of PyPC. A) Example of a smoothed and normalized fluorescence emission spectrum showing 
the areas (A1, A2 and A3) employed to evaluate the ratio between the excimer and monomer of PyPC (E/M). Dotted lines indi-
cate the average boundary wavelengths at which the absolute value of the first derivative of the spectrum reached a minimum. 
Temperature and excitation wavelength were 25°C and 340 nm, respectively. B) Estimated E/M ratios by relating the areas of 
the spectra using one of the two procedures shown in the legend. Error bars represent the S.D. of two independent samples. 
Arrows indicate the E/M values for the AChR-containing sample according to each procedure of calculation.
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0.123); c) a lower percentage of the y-variance explained
(67.6%) and d) a worse correlation between the predicted
and known DOPA molar fraction, as deduced from both
the lower R2 (0.920) and a slope far from unity (0.919).
Upon performing the first two pre-processing steps (i.e.
smoothing followed by normalization), PLS-1 was
applied again to the entire spectra (354–590 nm). The
model obtained at this stage exhibited improved perform-
ance (Fig. 2C), as can be inferred from the statistical
parameters (number of factors = 4; RMSEP, 0.060;% y-var-
iance explained, 92.9; R2 = 0.974; slope, 0.975). Finally,
by using only a restricted portion of the smoothed and
normalized spectra (434–590 nm) where the variability
between samples is at its highest, a model with higher pre-
diction capability could be constructed (Fig. 2A). Though
a similar pre-processing and statistical treatment was also
applied to the emission spectra (484–590 nm) of NBD-
Chol samples excited at 478 nm, no conclusive informa-
tion could be obtained by MA.
The apparent DOPA molar fraction in AChR-containing
samples was investigated at higher temperatures by apply-
ing PLS-1 to spectra at 40 and 55°C (Fig. 2D and 2E). The
predicted DOPA fraction in samples at 40°C was higher
(64 and 78%) than its actual value (20%), indicating that
AChR-phospholipid interactions, and hence the rigidify-
ing effect of the protein on the lipid matrix, remains even
at this temperature (Fig. 2D). Upon increasing the temper-
ature to 55°C the predicted DOPA molar fraction (Fig.
2E) showed minor differences in comparison to known
values (15 and 47% versus 20%). Although the model's
performance (RMSEP, 0.059;% y-variance explained,
91.3; R2 = 0.952; slope, 0.953) was not as good as with the
lower temperature samples and higher deviations were
apparent in the predicted values in AChR-containing sam-
ples, this finding suggests that interactions between the
protein and its surrounding lipid matrix decrease at such
high temperature.
3.4. PyPC excimer to monomer fluorescence ratio (E/M)
We also investigated lipid organization and fluidity in
reconstituted membranes by using PyPC, a lipid probe
having the fluorophore attached at the end of the 10-C
acyl chain. This fluorescent lipid partitions favorably into
lipid-fluid phases [14,15] and tends to form probe-
enriched domains ("patches") laterally segregated from
lipids in the gel state [23]. PyPC displays a phase behavior
similar to that of an unsaturated lipid with a low solubil-
ity in gel-state bilayers, which is usually attributed to poor
fitting of the pyrene moiety into tightly-packed lipids in
the gel state [14]. A very useful trait of pyrene probes,
PyPC included, is that they form excimers when a mole-
cule in the excited state collides with a molecule in the
ground state. This phenomenon depends on both the
concentration and lateral diffusion of the probe in the
lipid matrix [24,14,25,15]. Experimental measurement of
E/M can therefore be effectively used to sense changes in
the physical state and fluidity of the bilayer. E/M may
increase by a local (or apparent) augmented concentra-
tion of the probe owing to lateral segregation from the gel
state into probe-enriched domains (clusters), and/or by
an enhanced diffusion rate (fluidity).
E/M is usually calculated from the ratio between the fluo-
rescence intensity at the maximum emission band of the
excimer (~424 nm) and that of the monomer (~374 nm).
Monomer and excimer emission bands are dissected in
Additional file 1, in which reference spectra of the probe
are shown. We employ the full spectral information to
estimate E/M, instead of two wavelengths only, by calcu-
lating the ratio between the areas under the excimer and
the monomer emission bands (A2/A1 in Fig. 3A) in the
smoothed and normalized spectra. The two vertical dot-
ted lines in Fig. 3A denote boundary points between
regions, ascertained by averaging wavelengths of spectra
where the first derivative was closest to or equal to zero.
We also estimated E/M from the ratio between areas
below the PyPC excimer + NBD-Chol and monomer emis-
sion bands (A2+A3)/A1 to account for possible resonance
energy transfer to the latter probe (Fig. 3A).
No significant variation in tendency was observed in E/M in
AChR-free bilayers with changing DOPA molar fraction
using either calculation procedure (Fig. 3B), suggesting that
no appreciable lipid phase segregation and/or changes in flu-
idity occurred for any DOPA/DOPC molar ratio. This is not
surprising since both DOPA and DOPC are in the fluid state
at 25°C (Tm of DOPA and DOPC are -8 and -20°C, respec-
tively). The other factor possibly affecting E/M, i.e. fluidity,
will have remained constant, since temperature was kept
constant for all DOPA/DOPC combinations. Furthermore,
PyPC did not partition or segregate into clusters and was
most likely homogeneously distributed, i.e. no coexistence
of solid and liquid phases took place in DOPA/DOPC bilay-
ers at the working temperature.
When the AChR was incorporated into DOPA/DOPC (20/
40 molar ratio) bilayers, a lower value of E/M was found
as compared to AChR-free samples with any of the lipid
combinations tested and using any of the two calibration
procedures (Fig. 3B). The drop in E/M can be explained in
terms of a lower collisional rate of PyPC because of the
reduced diffusion rate/fluidity. Again, in view of the low
Tm values of the constitutive lipids it is unlikely that liquid
and solid lipid phases can form and coexist at 25°C owing
to the presence of the protein. The restricted diffusion of
PyPC is probably due to a higher lateral packing density
and a lower fluidity of the lipid matrix caused by the pres-
ence of the AChR, in agreement with the results obtained
for the apparent DOPA molar fraction in AChR-contain-
ing samples.Page 9 of 12
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The good spectral overlap between the fluorescence emis-
sion of Trp residues in the AChR protein (F330) [26,27]
and PyPC absorption bands (F340) enabled us to employ
FRET conditions by exciting samples at the protein main
absorption band (290 nm). Individual spectra of AChR
and PyPC are provided in Additional file 1. To investigate
the effect of temperature on lipid organization within
Förster's distances from the protein (reported to be ~28 Å,
ref. [28]), we estimated the apparent FRET between the
protein and the probe at 25, 40 and 55°C in AChR-con-
taining samples with a DOPA/DOPC/NBD-Chol
20:40:40 molar fraction. Instead of estimating FRET by
measuring the fluorescence decrease of the donor at one
wavelength only, we once again exploited the multivariate
spectral information by estimating FRET = 1-(A1/A2),
where A1 and A2 are the areas below the donor (AChR)
and acceptor (PyPC) emission bands as shown in Fig. 4.
Since a ratio (A1/A2) is used, smoothed spectra yield the
same results as those from smoothed + normalized spec-
tra. A1 and A2 were computed from 304 to 360 nm and
from 360 to 544 nm, respectively. The latter interval was
extended up to 544 nm to account for the overlapping
emission bands of fluorophores, changes in PyPC exci-
mer:monomer ratio, and FRET occurring between PyPC
excimer and NBD-Chol. By computing this extended
wavelength interval for A2, and not that of the monomer
band only (360–434 nm), all possible fluorescence sig-
nals beyond the PyPC monomer are accounted for.
FRET from the AChR to PyPC increased slightly upon
increasing the temperature from 25 to 55°C (inset in Fig.
4), suggesting a shorter distance between the FRET part-
ners, i.e. a closer AChR-PyPC contact.
In order to check that the increase in FRET = 1-(A1/A2) is
due to an energy transfer process and not to some other
phenomenon, spectra of AChR-only and PyPC-only sam-
ples were measured at the same temperatures (25, 40 and
55°C). Both A1 and A2 were found to diminish with tem-
perature but not at the same rate, yielding increasing val-
ues of A1/A2 (see Additional file 3) that translate into
lower [1-(A1/A2)] values in the control samples as temper-
ature increases. These findings validate the procedure for
calculating FRET and confirm that energy transfer
increases with increasing temperature.
4. Discussion
The crosstalk between the AChR and its lipid microenvi-
ronment was investigated by applying chemometric tools
to fluorescence spectra, an approach to our knowledge not
previously used to study lipid-AChR interactions. This
powerful statistical approach (PLS-1) enabled us to extract
otherwise masked spectral fluorescence data on protein-
lipid interactions under conditions known to affect the
functionality of the former [reviewed in [4]].
The PLS-1 model predicted higher DOPA molar fractions
(here termed "apparent") than their actual values in lipid
bilayers containing the AChR. These predictions emerge
from the MA applied over a selected portion of the ana-
lyzed spectra corresponding principally to the PyPC exci-
mer band, which reports on membrane fluidity. The
obtained information proved extremely difficult to extract
from the raw overlapping spectra (Figs. 1A–B) by utilizing
the maximum fluorescence intensity at one wavelength
only. MA enabled us to detect and correlate variations
across the entire spectra, establishing relationships
between those wavelengths that displayed a linear-like
correlation with the DOPA molar fraction. The model pre-
dicted a more rigid lipid matrix in the presence of the
AChR, on the basis of the higher apparent molar fraction
of the phospholipid with the highest Tm (DOPA).
Förster resonance energy transfer (FRET) from the AChRigure 4
Förster resonance energy transfer (FRET) from the 
AChR. Smoothened fluorescence emission spectrum of an 
AChR PyPC-containing sample at 25°C showing the areas 
(A1 and A2) used to evaluate FRET. The dotted line indicates 
the average boundary wavelength at which the absolute value 
of the first derivative of the spectrum passed through a mini-
mum. Excitation wavelength = 290 nm. Inset: FRET from 
AChR to PyPC as a function of temperature. FRET was calcu-
lated according to [1-(A1/A2)]. Liposomes contained DOPA/
DOPC/NBD-Chol at a molar fraction 20/40/40 and a lipid to 
protein molar ratio of 500:1. PyPC concentration was 5 
mol%. Error bars represent the S.D. of two independent 
samples.
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AChR revealed no appreciable changes in the diffusion
rate/fluidity with changing DOPA/DOPC molar ratios (Fig.
3B). This is not unexpected, since at 25°C both lipids are in
the fluid state. Since the experiment was performed above
30°C (i.e above the highest Tm of each lipid; -8° for DOPA)
it is also unlikely that lateral phase segregation occurred at
any of the assayed lipid molar ratios. Conversely, the drop
in the E/M upon incorporation of the AChR indicates that
the protein decreases the diffusion rate/fluidity of its sur-
rounding lipid matrix, in agreement with the results of the
apparent DOPA molar fraction experiments. E/M was also
found to decrease in studies of AChR reconstituted in a sin-
gle-phase DPPC bilayer and in coexisting liquid-solid bilay-
ers composed of POPA/POPC[28].
AChR-PyPC FRET experiments in DOPA/DOPC bilayers
revealed the preference of the AChR protein for DOPA
over DOPC, in agreement with previous results showing
favored interactions between PA and the AChR relative to
PC, PG and PS [6,7,30,29]. The AChR is included in PA-
enriched regions, separated from the bulk lipids [6,7]. We
hypothesized that with increasing temperature DOPA
molecules separate from the protein, whereas the oppo-
site occurs for DOPC molecules, which move closer to the
AChR. Owing to the augmented number of DOPC mole-
cules near the protein, FRET increases with increasing tem-
perature because a higher number of PyPC molecules
(with higher affinity for DOPC) come closer to the pro-
tein. In the case of lipid mixtures exhibiting liquid-solid
phase coexistence, i.e. having lipids with Tm's above and
below the working temperature, this enhanced affinity
could lead to segregation of PA-enriched domains from
the bulk lipid. In a liquid system such as the one used in
this work, where no liquid-solid phase segregation is
likely to occur, the minor increase in FRET with increasing
temperature can most economically be interpreted in
terms of a migration and re-distribution of the probe. The
mixing of lipids upon heating, and the resulting diffusion
of DOPC to regions near the AChR were mirrored by the
diffusion of PyPC, which partitions favorably in DOPC-
enriched domains. Thus, increasing temperature causes a
dispersion of DOPA and a concurrent enrichment of
DOPC and PyPC molecules in the immediate vicinity of
the AChR. AChR incorporation into PA-containing mem-
branes leads to an increase in both the lateral packing den-
sities and the Tm's of POPC/DOPA or POPC/POPA
mixtures, an effect which is absent in pure POPC bilayers
[7,30]. These changes are accompanied by an increase in
the percentage of non-hydrogen-bonded lipid ester carbo-
nyls, reinforcing the proposal that that the AChR reduces
water penetration at the polar head group-acyl chain
interface [5]. In the absence of the AChR protein, ideal
mixing of membrane components takes place, whereas
the presence of the protein leads to lateral phase segrega-
tion of certain lipids (DMPA) but not others (DMPC,
DMPG, DMPE) [7,31]. The promotion of lateral segrega-
tion of POPA from a liquid phase enriched in lipids hav-
ing identical acyl chains, such as POPC, leads to a tighter
lipid packing and to an increase in the Tm's of the lipid sys-
tem. PA is required for proper receptor function [32,33],
and its Tm is higher than that of non-functional bilayers
composed of PC only [7].
The ability of the AChR to selectively modulate the physi-
cal properties of the bilayer could stem essentially from a
hydrophobic mismatch between the AChR and the fatty
acyl chains and/or polar head groups. Such mismatch
could also play an important role in the modulation of
AChR function. The present results, obtained by applica-
tion of MA to complex spectra obtained under various flu-
orescence spectroscopy modalities (steady-state spectra,
FRET, excimer/monomer measurements) and exploiting
the intrinsic fluorescence of the AChR protein or extrinsic
fluorescent derivatives of phosphatidylcholine or choles-
terol, support the more general notion that the AChR
organizes its immediate environment with increased lat-
eral packing density and rigidity. The functional counter-
part of this finding is that ordered lipid membranes
stabilize the receptor in a resting, activatable state,
whereas fluid or disordered membranes favor a desensi-
tized conformation of the receptor protein.
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